Home Research COVID-19 Services Publications People Teaching Job Opening News Forum --> -->
Online Services

I-TASSER I-TASSER-MTD C-I-TASSER CR-I-TASSER QUARK C-QUARK LOMETS MUSTER CEthreader SEGMER DeepFold DeepFoldRNA FoldDesign COFACTOR COACH MetaGO TripletGO IonCom FG-MD ModRefiner REMO DEMO DEMO-EM DMFold SPRING COTH Threpp PEPPI BSpred ANGLOR EDock BSP-SLIM SAXSTER FUpred ThreaDom ThreaDomEx EvoDesign BindProf BindProfX SSIPe GPCR-I-TASSER MAGELLAN ResQ STRUM DAMpred

TM-score TM-align US-align MM-align RNA-align NW-align LS-align EDTSurf MVP MVP-Fit SPICKER HAAD PSSpred 3DRobot MR-REX I-TASSER-MR SVMSEQ NeBcon ResPRE TripletRes DeepPotential WDL-RF ATPbind DockRMSD DeepMSA FASPR EM-Refiner GPU-I-TASSER

BioLiP E. coli GLASS GPCR-HGmod GPCR-RD GPCR-EXP Tara-3D TM-fold DECOYS POTENTIAL RW/RWplus EvoEF HPSF THE-DB ADDRESS Alpaca-Antibody CASP7 CASP8 CASP9 CASP10 CASP11 CASP12 CASP13 CASP14

BioLiP
Download all results in tab-seperated text for 52 receptor-ligand interactions, whose format is explained at readme.txt.
  • Hover over PDB to view the title of the structure. Click PDB to view the structure at the RCSB PDB database. Resolution -1.00 means the resolution is unavailable, e.g., for NMR structures.
  • Click Site # to view the binding site structure. Hover over Site # to view the binding residues.
  • Hover over Ligand to view the full ligand name. Click Ligand to view the 2D diagram and other detail information of the ligand.
  • Hover over EC number to view the full name of enzymatic activity.
  • Hover over GO terms to view all GO terms.
  • Hover over UniProt to view the protein name.
  • Sort results by
    << < 1 > >>
    Go to page

    # PDB
    (Resolution Å)
    Site # Ligand EC number GO terms UniProt PubMed Binding
    affinity
    1 7spb:C1 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    2 7spb:C1 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    3 7spb:C10 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    4 7spb:C10 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    5 7spb:C11 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    6 7spb:C11 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    7 7spb:C12 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    8 7spb:C12 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    9 7spb:C13 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    10 7spb:C13 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    11 7spb:C2 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    12 7spb:C2 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    13 7spb:C3 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    14 7spb:C3 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    15 7spb:C4 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    16 7spb:C4 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    17 7spb:C5 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    18 7spb:C5 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    19 7spb:C6 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    20 7spb:C6 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    21 7spb:C7 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    22 7spb:C7 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    23 7spb:C8 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    24 7spb:C8 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    25 7spb:C9 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    26 7spb:C9 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    27 7spb:D1 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    28 7spb:D1 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    29 7spb:D10 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    30 7spb:D10 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    31 7spb:D11 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    32 7spb:D11 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    33 7spb:D12 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    34 7spb:D12 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    35 7spb:D13 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    36 7spb:D13 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    37 7spb:D2 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    38 7spb:D2 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    39 7spb:D3 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    40 7spb:D3 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    41 7spb:D4 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    42 7spb:D4 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    43 7spb:D5 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    44 7spb:D5 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    45 7spb:D6 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    46 7spb:D6 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    47 7spb:D7 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    48 7spb:D7 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    49 7spb:D8 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    50 7spb:D8 (3.31) BS02 peptide ? N/A Q8KNL8 N/A
    51 7spb:D9 (3.31) BS01 peptide ? N/A Q8KNL8 N/A
    52 7spb:D9 (3.31) BS02 peptide ? N/A Q8KNL8 N/A

    Reference:
  • Chengxin Zhang, Xi Zhang, Peter L Freddolino, and Yang Zhang. BioLiP2: an updated structure database for biologically relevent ligand-protein interactions, Nucleic Acids Research, gkad630 (2023).
  • Jianyi Yang, Ambrish Roy, and Yang Zhang. BioLiP: a semi-manually curated database for biologically relevant ligand-protein interactions, Nucleic Acids Research, 41: D1096-D1103 (2013) (download the PDF file).
  • yangzhanglabumich.edu | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218